Versant Development Fund III, L.P.
Insider CIK 1597416 · FLXN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FLXN Flexion Therapeutics Inc | P Buy | 2016-06-08 | 2016-06-10 | 710,091 | $14.00 | $9.94M | 3,511,670 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2016-06-08 | 2016-06-10 | 4,194 | $14.00 | $58.7K | 20,739 | SEC↗ |
| FLXN Flexion Therapeutics Inc | X Exercise deriv | 2014-09-10 | 2014-09-12 | 2,250 | — | $0 | 6,750 | SEC↗ |
| FLXN Flexion Therapeutics Inc | X Exercise | 2014-09-10 | 2014-09-12 | 2,250 | $17.61 | $39.6K | 2,250 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 18,512 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 3,135,165 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 2,900,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 97,797 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 16,558,351 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 2,277 | — | $0 | 2,899,115 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 385,629 | — | $0 | 2,896,838 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2014-02-18 | 2014-02-20 | 1,806 | $13.00 | $23.5K | 3,206,807 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 12,029 | — | $0 | 2,122,526 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 2,036,697 | — | $0 | 2,110,064 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2014-02-18 | 2014-02-20 | 305,886 | $13.00 | $3.98M | 3,205,001 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 356,703 | — | $0 | 2,511,209 | SEC↗ |